Table of Contents

company-logo

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also provides histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it engages in the trading of commodities and renting of properties. Further, the company exports its products. It offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquids orals, liquid vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and herbals. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore, India.

Syncom Formulations Dividend Announcement

• Syncom Formulations announced a annually dividend of ₹0.03 per ordinary share which will be made payable on 2022-10-19. Ex dividend date: 2022-09-09
• Syncom Formulations's trailing twelve-month (TTM) dividend yield is -%

Syncom Formulations Dividend History

Ex-Div dateDividend amountDividend typePay date
2022-09-09₹0.03annually2022-10-19
2017-09-21₹0.02annually2017-10-29

Syncom Formulations Dividend per year

Syncom Formulations Dividend Yield

Syncom Formulations current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Syncom Formulations stock? Use our calculator to estimate your expected dividend yield:

Syncom Formulations Financial Ratios

P/E ratio49.47
PEG ratio0.49
P/B ratio5.23
ROE11.61%
Payout ratio0.00%
Current ratio5.01
Quick ratio4.09
Cash Ratio0.01

Syncom Formulations Dividend FAQ

Does Syncom Formulations stock pay dividends?
Syncom Formulations does not currently pay dividends to its shareholders.
Has Syncom Formulations ever paid a dividend?
No, Syncom Formulations has no a history of paying dividends to its shareholders. Syncom Formulations is not known for its dividend payments.
Why doesn't Syncom Formulations pay dividends?
There are several potential reasons why Syncom Formulations would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Syncom Formulations ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Syncom Formulations has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Syncom Formulations a dividend aristocrat?
Syncom Formulations is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Syncom Formulations a dividend king?
Syncom Formulations is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Syncom Formulations a dividend stock?
No, Syncom Formulations is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Syncom Formulations stocks?
To buy Syncom Formulations you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Syncom Formulations stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.